论文部分内容阅读
至2005年末,日本肾脏病终末期肾功衰竭透析人数达257000人,每495人中就有1人是透析患者。糖尿病肾病新的治疗法得到确认,即使肾炎的诊疗不断进步,新透析人数每年也高达3·6万人,未见减少。日本肾功能<60%的患者约达2千万人,并显示其生命预后低下。为了抑制肾功衰竭患者的增加,世界各国纷纷采取措施,肾脏病对策已成为世界瞩目的课题。
By the end of 2005, the number of dialysis patients with end-stage renal failure in Japan with renal disease reached 257,000, of which 1 in 495 were dialysis patients. The new treatment of diabetic nephropathy was confirmed. Even though the diagnosis and treatment of nephritis progressed, the number of new dialysis patients was as high as 36,000 per year, with no decrease. In Japan, about 60% of patients with renal function have an estimated 20 million patients and show a low life expectancy. In order to inhibit the increase of patients with renal failure, countries all over the world have taken measures to counter the problem of kidney disease has become a world’s attention issue.